Prognostic significance of the immunophenotype versus the international prognostic index in aggressive non-Hodgkin's lymphoma

Clinical Lymphoma

Volumn 4, Issue 1, 2003, Pages 52-55

  Intragumtornchai, Tanin ^a   Rotnakkarin, Ponlapat ^a   Sutcharitchan, Pranee ^a   Wannagrairoj, Pongsak ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

B cell lymphoma; Prognostic factors; T cell lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PERFORMANCE; PERIPHERAL T CELL LYMPHOMA; PROGNOSIS; RETROSPECTIVE STUDY; T CELL LYMPHOMA;

EID: 0037677686     PISSN: 15269655     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2003.n.014     Document Type: Article

References (21)

1. The International Non-Hodgkin's Lymphoma Prognostic Factor Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329:987-994.
2. Harris NY, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-1392.
3. Cox DR. Regression models and life tables. J R Stat Soc Series B 1972; 34:187-220.
4. Armitage JO, Vose JM, Linder J, et al. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma. J Clin Oncol 1989; 7:1783-1790.
5. Coiffier B, Berger F, Bryon P, et al. T-cell lymphomas: immunologic, histologic, clinical and therapeutic analysis of 63 cases. J Clin Oncol 1988; 6: 1584-1589.
6. Lippman SM, Miller TP, Spier CM, et al. The prognostic significance of the immunophenotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype. Blood 1988; 72:436-441.
7. Cheng A, Chen Y, Wang C, et al. Direct comparison of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades-Should peripheral T-cell lymphoma be considered separately? J Clin Oncol 1989; 7:725-731.
8. Kwak LK, Wilson M, Weiss LM, et al. Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience. J Clin Oncol 1991; 9:1426-1431.
9. Coiffier B, Brousse N, Peuchmaur M, et al. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. Ann Oncol 1990; 50:45-50.
10. Shimoyama M, Oyama A, Tajima K, et al. Differences in clinicopathological characteristics and major prognostic factors between B-lymphoma and peripheral T-lymphoma excluding adult T-cell leukemia/lymphoma. Leuk Lymphoma 1993; 10:335-342.
11. Liang R, Todd D, Ho FC. Aggressive non-Hodgkin's lymphoma: T-cell versus B-cell. Hematol Oncol 1996; 14:1-6.
12. Gisselbrecht C, Gaulard P, Lepage E, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Blood 1998; 92:76-82.
13. Melnyk A, Rodriguez A, Pugh WC, et al. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 1997; 89:4514-4520.
14. Lee SS, Cho KJ, Kim CW, et al. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the Revised European-American classification of lymphoid neoplasms. Histopathology 1999; 35:345-354.
15. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89:3909-3918.
16. Pittaluga S, Bijnens L, Teodorovic I, et al. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American classification of lymphoid neoplasms: a comparison with the Working Formulation. Blood 1996; 87:4358-4367.
17. Ko Y, Kim C, Park C, et al. REAL classification of malignant lymphomas in the Republic of Korea. Cancer 1998; 83:806-812.
18. Chuang SS, Lin CN, Li CY. Malignant lymphomas in southern Taiwan according to the revised European-American classification of lymphoid neoplasms. Cancer 2000; 89:1586-1592.
19. Isobe K, Tamaru J, Harigaya K, et al. Clinicopathological evaluation of the Revised European-American Classification of Lymphoid Neoplasms (REAL) in Japan. Leuk Lymphoma 1999; 34:143-149.
20. Lopez-Guillermo A, Montserrat E, Bosch F, et al. Applicability of the international index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 1994; 12:1343-1348.
21. Kaiser U, Uebelacker I, Havemann K. Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: a report on 58 patients. Leuk Lymphoma 1999; 36:101-108.